A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
Clinical trial NCT07522970 · RECRUITING
Trial details
- NCT number
- NCT07522970
- Sponsor
- LinGang Laboratory
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2026-09-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.